Using stored tumor tissue after surgery for advanced ovarian cancer
Part of Cancer, Hormones & metabolism, Women’s health & pregnancy clinical trials.
This study looks at archived tumor tissue samples from people with advanced (stage III or IV) ovarian epithelial cancer who had surgery and standard “platinum/taxol” chemotherapy trials. It may help researchers understand the cancer better and improve future treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have stage III or stage IV ovarian “epithelial” cancer
- You were enrolled in the specific Gynecologic Oncology Group (GOG) studies listed, including a front-line platinum/taxol chemotherapy trial
- You have stored tumor tissue from your primary surgery kept as paraffin blocks
- You had surgery to remove as much tumor as possible (either “optimal” or “suboptimal”); either can qualify
- Your records include enough information about you and follow-up outcomes
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how changes in your immune system's T-cells (measured from blood samples) can help predict if ovarian cancer comes back. If you are newly diagnosed with advanced ovarian cancer and planning standard treatments (surgery plus chemo), you may join.
This study looks at the genetic information (DNA) from your blood and from saved tumor tissue to better understand certain cancers, especially rare cancers with a poor outlook. It may help researchers learn why these cancers behave the way they do and guide future treatments.
This study collects and stores tissue from people with breast cancer or other gynecologic cancers to do DNA (genomics) testing. It may help researchers better understand these cancers by comparing genetic patterns from real patient tissue.
This study looks at “biomarkers,” meaning measurable signals in blood and tumor tissue, in people with advanced ovarian-type cancers. The goal is to understand these markers and how they relate to the cancer, which may help guide future care.
This study looks at tumor tissue from ovarian cancer patients to find “biomarkers,” or lab signals, that may predict how the disease behaves or how it might respond to treatment. You may be asked for a biopsy of the relapsed (coming back) tumor or to use an existing archived tumor sample.
This study uses lab testing to create a “map” of ovarian cancer cells one cell at a time, to better understand the disease. It likely helps researchers learn which cell types are involved, using samples collected around your surgery.
Hear when a new Stage IIIA Ovarian Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.